These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25230678)

  • 1. Relationship between coronary artery disease and C-reactive protein levels in NSTEMI patients with renal dysfunction: a retrospective study.
    Udeanu M; Guizzardi G; Di Pasquale G; Marchetti A; Romani F; Dalmastri V; Capelli I; Stalteri L; Cianciolo G; Rucci P; La Manna G
    BMC Nephrol; 2014 Sep; 15():152. PubMed ID: 25230678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Chronic Kidney Disease on Cardiovascular and Renal Events in Patients Undergoing Percutaneous Coronary Intervention with Everolimus-Eluting Stent: Risk Stratification with C-Reactive Protein.
    Dan K; Miyoshi T; Nakahama M; Mizuno T; Kagawa K; Naito Y; Kawada S; Ito H
    Cardiorenal Med; 2018; 8(2):151-159. PubMed ID: 29617004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do associations with C-reactive protein and extent of coronary artery disease account for the increased cardiovascular risk of renal insufficiency?
    Zebrack JS; Anderson JL; Beddhu S; Horne BD; Bair TL; Cheung A; Muhlestein JB;
    J Am Coll Cardiol; 2003 Jul; 42(1):57-63. PubMed ID: 12849660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of renal function on mean platelet volume and its relationship with coronary artery disease: A single-centre cohort study.
    Verdoia M; Barbieri L; Schaffer A; Bellomo G; Marino P; De Luca G;
    Thromb Res; 2016 May; 141():139-44. PubMed ID: 27039166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between the Serum Uric Acid Level and the Severity of Coronary Artery Disease in a Retrospective Study of China Nondialysis CKD Patients.
    Yang Y; Lin LH; Gao M; Tang RN; Ma KL; Tu Y; Liu H; Liu BC
    Metab Syndr Relat Disord; 2020 May; 18(4):206-211. PubMed ID: 32069163
    [No Abstract]   [Full Text] [Related]  

  • 6. Procalcitonin in patients with acute coronary syndrome: correlation with high-sensitive C-reactive protein, prognosis and severity of coronary artery disease.
    Sentürk T; Cordan J; Baran I; Ozdemir B; Güllülü S; Aydinlar A; Göral G
    Acta Cardiol; 2007 Apr; 62(2):135-41. PubMed ID: 17536601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of cardiac troponin I levels (10 folds upper limit of normal) and extent of coronary artery disease in non-ST elevation myocardial infarction.
    Qadir F; Farooq S; Khan M; Hanif B; Lakhani MS
    J Pak Med Assoc; 2010 Jun; 60(6):423-8. PubMed ID: 20527635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of prognostic patients with non-ST-segment elevation acute myocardial infarction and clinical characteristics of those with renal dysfunction].
    Zhu HN; Huo Y; Jiang J; Zhang Y; Kang AC; He H
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Oct; 40(5):533-7. PubMed ID: 18931720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uric acid does not affect the prevalence and extent of coronary artery disease. Results from a prospective study.
    De Luca G; Secco GG; Santagostino M; Venegoni L; Iorio S; Cassetti E; Verdoia M; Coppo L; Di Mario C; Bellomo G; Marino P;
    Nutr Metab Cardiovasc Dis; 2012 May; 22(5):426-33. PubMed ID: 21186110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy- Thrombolysis in Myocardial Infarction 18 trial)substudy.
    Sabatine MS; Morrow DA; Cannon CP; Murphy SA; Demopoulos LA; DiBattiste PM; McCabe CH; Braunwald E; Gibson CM
    J Am Coll Cardiol; 2002 Nov; 40(10):1761-8. PubMed ID: 12446059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal timing of coronary angiograms for patients with chronic kidney disease: association between the duration of kidney dysfunction and SYNTAX scores.
    Song B; Dai D; Liu S; Zhu Z; Ding F; Zhu J; Zhang R
    Ren Fail; 2021 Dec; 43(1):307-312. PubMed ID: 33538236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uric acid as a link between renal dysfunction and both pro-inflammatory and prothrombotic state in patients with metabolic syndrome and coronary artery disease.
    Zapolski T; Waciński P; Kondracki B; Rychta E; Buraczyńska MJ; Wysokiński A
    Kardiol Pol; 2011; 69(4):319-26. PubMed ID: 21523662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic inflammation in patients with chronic obstructive pulmonary disease undergoing percutaneous coronary intervention.
    Zhang XL; Chi YH; Wang le F; Wang HS; Lin XM
    Respirology; 2014 Jul; 19(5):723-9. PubMed ID: 24750361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between C-reactive protein-to-albumin ratio and the extent of coronary artery disease in patients with non-ST-elevated myocardial infarction.
    Kalyoncuoglu M; Durmus G
    Coron Artery Dis; 2020 Mar; 31(2):130-136. PubMed ID: 31233399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guideline adherence after ST-segment elevation versus non-ST segment elevation myocardial infarction.
    Somma KA; Bhatt DL; Fonarow GC; Cannon CP; Cox M; Laskey W; Peacock WF; Hernandez AF; Peterson ED; Schwamm L; Saxon LA
    Circ Cardiovasc Qual Outcomes; 2012 Sep; 5(5):654-61. PubMed ID: 22949493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis.
    deFilippi C; Wasserman S; Rosanio S; Tiblier E; Sperger H; Tocchi M; Christenson R; Uretsky B; Smiley M; Gold J; Muniz H; Badalamenti J; Herzog C; Henrich W
    JAMA; 2003 Jul; 290(3):353-9. PubMed ID: 12865376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory markers, angiographic severity of coronary artery disease, and patient outcome.
    Sukhija R; Fahdi I; Garza L; Fink L; Scott M; Aude W; Pacheco R; Bursac Z; Grant A; Mehta JL
    Am J Cardiol; 2007 Apr; 99(7):879-84. PubMed ID: 17398176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The burden of major adverse cardiac events in patients with coronary artery disease.
    Tsai IT; Wang CP; Lu YC; Hung WC; Wu CC; Lu LF; Chung FM; Hsu CC; Lee YJ; Yu TH
    BMC Cardiovasc Disord; 2017 Jan; 17(1):1. PubMed ID: 28052754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.
    Parikh PB; Jeremias A; Naidu SS; Brener SJ; Lima F; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):352-7. PubMed ID: 22566286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of growth differentiation factor 15 in patients with stable and acute coronary artery disease. A prospective observational study.
    Farhan S; Freynhofer MK; Brozovic I; Bruno V; Vogel B; Tentzeris I; Baumgartner-Parzer S; Huber K; Kautzky-Willer A
    Cardiovasc Diabetol; 2016 Apr; 15():60. PubMed ID: 27056183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.